Mentioned On
Episode Mentions
CNBC's "Fast Money" · May 5, 2026
Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26
“Licensing partner for Protagonist's Rasvertide drug for rare blood disease; expected FDA approval Q3 2026”
AI Infrastructure Investment and Chip CompetitionCloud Computing Backlog Concentration RiskSemiconductor Market Diversification from NVIDIA
View Analysis